Dana-Farber’s John Quackenbush on how to fix our “messy data” problem
On day two of MedCity CONVERGE, John Quackenbush of the Dana-Farber Cancer Institute highlighted the benefits and the challenges that accompany big data.
Precision medicine 2.0
“Single mutations or single genomic alterations are only really getting us part of the way to a solution,” said John Quackenbush, director of the Center for Cancer Computational Biology and a keynote speaker at MedCity CONVERGE, on the state of precision medicine.
What Are Healthcare Organizations Getting Wrong about Email Security?
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.